The following column was originally published May 28, 2022. Thanks to breakthroughs in medicine and nutrition in recent years, we are living longer than ever before. But this increase in life ...
NEWS10 ABC on MSN17h
A love story for the ages: 45 years of Valentine’s DayRoger and Linda Shafer got married in 1980 on Valentine's Day. They had a family with children and several grandchildren, and ...
Alpha-synuclein inhibitors are a class of investigational therapies targeting the pathological aggregation of alpha-synuclein, a protein implicated i ...
For the purpose of designing the patient-based model for Dementia with Lewy Bodies (DLB), the report provides historical as well as forecasted epidemiology segmented by Total Prevalent Cases of ...
A new Swedish study has, for the first time, shown a link between rheumatoid arthritis (RA) and cognitive decline in dementia ...
Lewy body dementia, family dynamics, long-buried secrets and murder are the story threads woven through “Carolina Moonset,” the 2024 One Book, One Community selection for Hutchinson.
CervoMed (CRVO) provided an update on its neflamapimod development program in dementia with Lewy bodies, DLB, as part of an oral presentation ...
About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...
About Dementia with Lewy Bodies (DLB) DLB is the third most common degenerative disease of the brain (after Alzheimer’s disease and Parkinson’s disease), with approximately 700,000 individuals ...
Cognition Therapeutics, Inc. announced promising results from the SHIMMER study of zervimesine (CT1812) in patients with mild-to-moderate dementia with Lewy bodies (DLB), to be presented by Dr ...
Cognition Therapeutics (CGTX) announced that JamesGalvin, MD, MPH will present topline results from the ‘SHIMMER’ study of zervimesine in ...
The initial topline results for the Phase 2b study of neflamapimod in dementia with Lewy bodies (DLB) were previously disclosed on December 10, 2024 and are available here. CervoMed Inc. is a clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback